摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

{3-[1-(2-cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl]-1,1-dioxo-1,4-dihydrobenzo[1,2,4]thiadiazin-7-yloxy}acetic acid | 477931-96-7

中文名称
——
中文别名
——
英文名称
{3-[1-(2-cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl]-1,1-dioxo-1,4-dihydrobenzo[1,2,4]thiadiazin-7-yloxy}acetic acid
英文别名
2-[[3-[1-(2-cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxo-3-quinolyl]-1,1-dioxo-4H-1$l^{6},2,4-benzothiadiazin-7-yl]oxy]acetic acid;2-[[3-[1-(2-cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxoquinolin-3-yl]-1,1-dioxo-4H-1λ6,2,4-benzothiadiazin-7-yl]oxy]acetic acid
{3-[1-(2-cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl]-1,1-dioxo-1,4-dihydrobenzo[1,2,4]thiadiazin-7-yloxy}acetic acid化学式
CAS
477931-96-7
化学式
C23H20FN3O7S
mdl
——
分子量
501.492
InChiKey
HSSIVANTQPVYSA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    35
  • 可旋转键数:
    7
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    154
  • 氢给体数:
    3
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    {3-[1-(2-cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl]-1,1-dioxo-1,4-dihydrobenzo[1,2,4]thiadiazin-7-yloxy}acetic acid甲胺N-羟基-7-氮杂苯并三氮唑 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 以27%的产率得到2-{3-[1-(2-cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl]-1,1-dioxo-1,4-dihydro-1-benzo[1,2,4]thiadiazin-7-yloxy}-N-methylacetamide
    参考文献:
    名称:
    Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase
    摘要:
    The synthesis and optimisation of HCV NS5B polymerase inhibitors with improved potency versus the existing compound 1 is described. Substitution in the benzothiadiazine portion of the molecule, furnishing improvement in potency in the high protein Replicon assay, is highlighted, culminating in the discovery of 12h, a highly potent oxyacetamide derivative. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.05.091
  • 作为产物:
    描述:
    1-(2-cyclopropylethyl)-6-fluoro-4-hydroxy-3-(7-hydroxy-1,1-dioxo-1,4-dihydrobenzo[1,2,4]thiadiazin-3-yl)-1H-quinolin-2-one氯乙酸 在 sodium hydride 作用下, 以 N,N-二甲基甲酰胺 、 mineral oil 为溶剂, 反应 4.25h, 以67%的产率得到{3-[1-(2-cyclopropylethyl)-6-fluoro-4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl]-1,1-dioxo-1,4-dihydrobenzo[1,2,4]thiadiazin-7-yloxy}acetic acid
    参考文献:
    名称:
    Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase
    摘要:
    The synthesis and optimisation of HCV NS5B polymerase inhibitors with improved potency versus the existing compound 1 is described. Substitution in the benzothiadiazine portion of the molecule, furnishing improvement in potency in the high protein Replicon assay, is highlighted, culminating in the discovery of 12h, a highly potent oxyacetamide derivative. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.05.091
点击查看最新优质反应信息

文献信息

  • [EN] NOVEL ANTI-INFECTIVES<br/>[FR] NOUVEAUX ANTI-INFECTIEUX
    申请人:SMITHKLINE BEECHAM CORP
    公开号:WO2002098424A1
    公开(公告)日:2002-12-12
    Compounds useful as HCV anti-infectives having the formula: wherein the formula variables are as defined herein, are disclosed. Also disclosed are methods of making and using the same.
    本发明揭示了具有以下式的HCV抗感染剂有用的化合物:其中,公式变量如本文所定义。同时还揭示了制备和使用该化合物的方法。
  • Novel anti-infectives
    申请人:——
    公开号:US20040147739A1
    公开(公告)日:2004-07-29
    Compounds useful as HCV anti-infectives having the formula: wherein the formula variables are as defined herein, are disclosed. Also disclosed are methods of making and using the same.
    本文披露了具有以下公式的HCV抗感染剂有用的化合物:其中公式变量如本文所定义。同时,还披露了制备和使用这些化合物的方法。
  • EP1401443A4
    申请人:——
    公开号:EP1401443A4
    公开(公告)日:2005-10-26
  • NOVEL ANTI-INFECTIVES
    申请人:SMITHKLINE BEECHAM CORPORATION
    公开号:EP1401443A1
    公开(公告)日:2004-03-31
  • Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase
    作者:Antony N. Shaw、Rosanna Tedesco、Ramesh Bambal、Deping Chai、Nestor O. Concha、Michael G. Darcy、Dashyant Dhanak、Kevin J. Duffy、Duke M. Fitch、Adam Gates、Victor K. Johnston、Richard M. Keenan、Juili Lin-Goerke、Nannan Liu、Robert T. Sarisky、Kenneth J. Wiggall、Michael N. Zimmerman
    DOI:10.1016/j.bmcl.2009.05.091
    日期:2009.8
    The synthesis and optimisation of HCV NS5B polymerase inhibitors with improved potency versus the existing compound 1 is described. Substitution in the benzothiadiazine portion of the molecule, furnishing improvement in potency in the high protein Replicon assay, is highlighted, culminating in the discovery of 12h, a highly potent oxyacetamide derivative. (C) 2009 Elsevier Ltd. All rights reserved.
查看更多